← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Juvaris Biotherapeutics, Inc.
Burlingame, CA
$10,010,093
Total funding
7
Grants
Funding over time
peak $2.7M · FY2006–11$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$10,010,093 · 7
By mechanism
U01$7,037,188 · 1
R43$2,158,056 · 5
R41$814,849 · 1
Investigators at Juvaris Biotherapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Adjuvant Enhanced Antiviral Immunity$1,829,840
U01 · FY2010 · AI
Adjuvant Enhanced Antiviral Immunity$1,694,391
U01 · FY2009 · AI
Adjuvant Enhanced Antiviral Immunity$1,666,026
U01 · FY2007 · AI
Adjuvant Enhanced Antiviral Immunity$1,586,243
U01 · FY2008 · AI
Innate Immune Stimulation as a Pathogen Countermeasure$500,833
R43 · FY2006 · AI
Innate Immune Stimulation as a Pathogen Countermeasure$475,027
R43 · FY2007 · AI
Lipid/DNA/Antigen Complexes for Influenza A Viral Vaccination$447,587
R41 · FY2006 · AI
Novel Immunostimulant/Adjuvant for HIV Vaccines: Non-Human Primate Studies$385,029
R43 · FY2006 · AI
Lipid/DNA/Antigen Complexes for Influenza A Viral Vaccination$367,262
R41 · FY2007 · AI
Adjuvant Enhanced Antiviral Immunity$260,688
U01 · FY2011 · AI
Immune Response Modification for Treatment of Hepatocellular Carcinoma$255,467
R43 · FY2008 · CA
Cationic Lipid/DNA/Antigen Complexes for Leukemia Vaccines$225,497
R43 · FY2006 · CA
Lipid/DNA/Antigen Complexes for Pseudomonas vaccines$164,619
R43 · FY2004 · AI
Novel Immunostimulant/Adjuvant for HIV Vaccines: Non-Human Primate Studies$151,584
R43 · FY2007 · AI